ReWalk Robotics (RWLK) & Wright Medical Group N.V. (NASDAQ:WMGI) Critical Review
ReWalk Robotics (NASDAQ: RWLK) and Wright Medical Group N.V. (NASDAQ:WMGI) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitabiliy, dividends, analyst recommendations, risk and valuation.
Volatility & Risk
ReWalk Robotics has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Comparatively, Wright Medical Group N.V. has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500.
Valuation & Earnings
This table compares ReWalk Robotics and Wright Medical Group N.V.’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|ReWalk Robotics||$6.31 million||3.57||-$28.97 million||($1.94)||-0.70|
|Wright Medical Group N.V.||$707.24 million||4.14||$79.35 million||($2.46)||-11.41|
Wright Medical Group N.V. has higher revenue and earnings than ReWalk Robotics. Wright Medical Group N.V. is trading at a lower price-to-earnings ratio than ReWalk Robotics, indicating that it is currently the more affordable of the two stocks.
This table compares ReWalk Robotics and Wright Medical Group N.V.’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Wright Medical Group N.V.||-36.04%||-6.22%||-1.81%|
This is a summary of recent ratings and target prices for ReWalk Robotics and Wright Medical Group N.V., as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Wright Medical Group N.V.||0||4||7||0||2.64|
ReWalk Robotics currently has a consensus price target of $4.63, indicating a potential upside of 242.59%. Wright Medical Group N.V. has a consensus price target of $32.25, indicating a potential upside of 14.93%. Given ReWalk Robotics’ higher possible upside, equities research analysts clearly believe ReWalk Robotics is more favorable than Wright Medical Group N.V..
Insider & Institutional Ownership
4.7% of ReWalk Robotics shares are owned by institutional investors. 13.7% of ReWalk Robotics shares are owned by insiders. Comparatively, 3.5% of Wright Medical Group N.V. shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Wright Medical Group N.V. beats ReWalk Robotics on 8 of the 13 factors compared between the two stocks.
ReWalk Robotics Company Profile
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. ReWalk designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities, and is custom fitted for each user. ReWalk Rehabilitation is designed for use by paraplegia patients in the clinical rehabilitation environment, where it provides exercise and therapy.
Wright Medical Group N.V. Company Profile
Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Company’s business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Company’s products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.
Receive News & Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related companies with MarketBeat.com's FREE daily email newsletter.